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The amyloid precursor protein (APP) is well known to be involved in the pathophysiology
of Alzheimer’s disease (AD) via its cleavage product amyloid ß (Aß). However, the
physiological role of APP, its various proteolytic products and the amyloid precursor-like
proteins 1 and 2 (APLP1/2) are still not fully clarified. Interestingly, it has been shown
that learning and memory processes represented by functional and structural changes
at synapses are altered in different APP and APLP1/2 mouse mutants. In addition,
APP and its fragments are implicated in regulating synaptic strength further reinforcing
their modulatory role at the synapse. While APLP2 and APP are functionally redundant,
the exclusively CNS expressed APLP1, might have individual roles within the synaptic
network. The proteolytic product of non-amyloidogenic APP processing, APPsα,
emerged as a neurotrophic peptide that facilitates long-term potentiation (LTP) and
restores impairments occurring with age. Interestingly, the newly discovered η-secretase
cleavage product, An-α acts in the opposite direction, namely decreasing LTP. In this
review we summarize recent findings with emphasis on the physiological role of the APP
gene family and its proteolytic products on synaptic function and plasticity, especially
during processes of hippocampal LTP. Therefore, we focus on literature that provide
electrophysiological data by using different mutant mouse strains either lacking full-length
or parts of the APP proteins or that utilized secretase inhibitors as well as secreted APP
fragments.
Keywords: amyloid precursor protein, amyloid precursor-like protein, long-term potentiation, synaptic plasticity
INTRODUCTION
The amyloid precursor protein (APP) gene is localized in humans on chromosome 21 and its
expression gives rise to three major isoforms (APP695, APP751, APP770; around 170 kDa)
generated via alternative splicing. APP695 is the predominant isoform in neurons (Robakis et al.,
1987; Yoshikai et al., 1990). APP is translated in the endoplasmatic reticulum (ER) where it forms
stable dimers which are transported through the secretory pathway via the Golgi apparatus to the
cell surface (Isbert et al., 2012; Tan and Evin, 2012). APP is classified as a type I transmembrane
glycoprotein with one membrane spanning domain, a large extracellular N-terminus and a small
intracellular C-terminus (Dyrks et al., 1988). The mammal APP is part of a larger gene family
including the homologs amyloid precursor-like proteins 1 and 2 (APLP1 and APLP2), both of
Ludewig and Korte Role of APP in Synaptic Plasticity
which are expressed throughout the body nervous system (brain,
spinal cord, retina), immune system (thymus, spleen), muscle
(smooth, cardiac, and skeletal), kidney, lung, pancreas, prostate
gland, and thyroid gland (Wasco et al., 1993; Liu et al., 2008;
Aydin et al., 2012). Interestingly, the APP and APLP2 proteins
are found at particularly high levels in the brain where their
expression patterns largely overlap in pyramidal neurons of the
cortex and hippocampus (Bendotti et al., 1988; Lorent et al.,
1995). Thereby, the APP isoform APP695 is especially found in
excitatory neurons as well as in GABAergic interneurons while
the expression of the other two isoforms, 751 and 770, is assigned
to other cell types (Wang et al., 2014; Hick et al., 2015). In vitro
studies revealed APP expression in astrocytes and microglia that
is increased following brain injury (LeBlanc et al., 1997; Rohan de
Silva et al., 1997). On the other hand amore recent study reported
that APP expression is restricted to neurons and cannot be found
in major glial cells like astrocytes or microglia under basal as
well as neuroinflammatory conditions (Guo et al., 2012). These
contradictory results are possibly due to the lack of APP specific
antibodies. The highly homologous APP family members differ
only slightly in their peptide domain structure and hence are
displaying a similar proteolytic processing. The relatively short
intracellular part of the C-terminus of APP and related proteins
contains a YENPTY peptide motif which was shown to promote
clathrinmediated endocytosis, modulate Aβ generation, interfere
with Ca2+ homeostasis, and interact with multiple kinases, and
adapter proteins (Perez et al., 1999; Leissring et al., 2002; Ring
et al., 2007; Jacobsen and Iverfeldt, 2009). The extracellular part
of APP is composed of the large E2 and E1 domains containing
interaction sites for multiple binding partners like F-spondin,
LRP1, Nogo-66 receptor, Notch 2, Netrin, Alcadein, sorL1/LR11,
and extracellular matrix components (Müller and Zheng, 2012).
Additionally, the E1 domain could be demonstrated to be crucial
for the homo- and heterodimerization of APP family members
(Soba et al., 2005). Interestingly, the Aβ motive, which is highly
conserved in mammals and zebrafish is unique for APP. The
APLPs lack this sequence.
Although the structure of both APP and APLPs are well
known, the precise cellular function of these proteins remains
elusive. For instance, extensive posttranslational modifications
and the various cleavage products of APP and APLP processing
complicate precise investigations. Nevertheless, several studies
assessed putative cellular functions of the APP family members
during development and in the adult nervous system (Jacobsen
and Iverfeldt, 2009). Certainly, one of the most intriguing
discoveries in this respect is the involvement of APP and its
cleavage products in processes of synaptic plasticity (Korte
et al., 2012) at which activity patterns generated by experience
are able to modify neuronal function and structure. These
include activity-dependent alterations of the efficacy of synaptic
transmission and changes in the structure and number of
synaptic connections (for a review see Korte and Schmitz, 2016).
Part of the pathophysiology of Alzheimer’s disease (AD) is related
to the malfunction of synapses (Selkoe, 2002) and the application
of amyloid beta (Aß) oligomers has been shown to directly
impair synaptic plasticity (Shankar et al., 2008). Despite a huge
amount of data which looked at the pathophysiological role of
Aß plaques, it is less clear what the physiological function of APP
and its fragments (including Aß) might be. In addition to APP,
it is also important to further the understanding of the putative
physiological functions of the related APLP1 and APLP2 proteins
and their cleavage products. In this review we concentrate on
the role of APP, APLP1, APLP2, and their proteolytic fragments
in processes of synaptic transmission and in particular synaptic
plasticity under physiological conditions (Table 1).
ROLE OF FULL-LENGTH APP PROTEINS
AT THE SYNAPSE
Gene targeting of APP protein family members provides a
powerful tool to investigate the proteins functions. Studying
adult APP and APLP2 single KOs in synaptic plasticity revealed
only subtle phenotypes (von Koch et al., 1997) mainly due to
the overlapping ubiquitous expression of the two proteins in
mammals and their similar processing (see Figure 1). Under
steady state conditions, the majority of full-length APP is
located in the Golgi apparatus and in the trans-Golgi network
(Thinakaran and Koo, 2008). When present at the plasma
membrane APP and APLPs were shown to form homo- and
heterotypic cis interactions and have been proposed to mediate
cell–cell interactions in trans (Soba et al., 2005; Kaden et al., 2009;
Baumkötter et al., 2012; Mayer et al., 2016). Synaptic adhesion by
APP might not only be crucial to build and maintain synaptic
contacts, but also to regulate synaptic plasticity (see Figure 2).
Highest expression levels at the membrane were observed for
APLP1 suggesting that it might be the family member with
the upmost potential to mediate cell contacts (Kaden et al.,
2009). Recently, the study of Mayer et al. (2016) identified
APP and APLP2 to exhibit basal adhesive properties while
APLP1 mediated neuronal adhesion is dynamic and regulated
by zinc. Copper was instead shown to induce cis- and trans-
dimerization of APP at its E1 domain (Baumkötter et al.,
2014). Importantly enhanced trans or cis interaction of APPs or
APLPs is accompanied by a reduction of ectodomain shedding
of the proteins (Stahl et al., 2014; Mayer et al., 2016) and
might therefore interfere with the ability to modulate synaptic
function.
APP-KO
The well-studied constitutive KO of APP in mice leads to an
age-related deficit in synaptic plasticity, mainly in long-term
potentiation (LTP, see Box 1 for definition). LTP reflects the
increase in synaptic strength that lasts for at least 1 h and
is paralleled by alterations at the contact sites between nerve
cells, the presynapse (axonal boutons) and postsynapse (dendritic
spines). No alterations in synaptic plasticity, the cellular correlate
for learning and memory (Stuchlik, 2014) were found in
young mice accompanied by normal basal synaptic transmission
properties and short-term synaptic plasticity (STP) paralleling
the intact behavioral learning of adult and impaired performance
of agedmice (Seabrook et al., 1999; Ring et al., 2007; and reviewed
by Turner et al., 2003; Korte et al., 2012). The age-dependent
LTP defect is further supported by the electrophysiological
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TABLE 1 | Electrophysiological characteristics of the APP protein family members and their proteolytic domains.
FL-APP or fragment Species/Methodic details Electrophysiological relevant observations References
APPsα Adult, male Sprague-Dawley rats (1) Reduction of LTP in DG by up to 50% in vivo Taylor et al., 2008
Intrahippocampal infusion of (2.1) Enhancement of LTP at the PP-DG by 11
nm rec APPsa in vivo
(1) Antibodies targeting endogenous APPsα (2.2) Increase of NMDA-R EPSC amplitude at
PP-DG by 0.03 nm APPsα in vitro
(2) Recombinant APPsα (0.3, 3, 11, 330, 1000, 3300 nm) (3.1) Reduction of LTP in DG in vivo and
(3) α-Secretase inhibitor tapi-1 (500 nm) (3.2) Reduction of tetanus-evoked NMDA-R
currents in DG cells in vitro
Acute hippocampal slices of Sprague-Dawley rats (young
= 3–6 months and aged = 24–27 months)
Increases NMDA-R activation in aged animals
Rescues age-related LTP deficits
No effect on basal synaptic transmission or
glutamate release (PPF)
Moreno et al., 2015
Exogenous, recombinant APPsα application
(0.1–1–10 nm)
Dose-dependent increase of NMDA-R
related ISE
Rat OHCs treated for up to 24 h with APPsα
(0.03–0.1–1–10 nm)
1 nm appsα reduces NMDA toxicity
Facilitation of LTP expression in aged animals
by induction of plasticity-associated immediate
early genes
Ryan et al., 2013
Acute hippocampal slices of adult, APP/APLP2
conditional DKO mice
Rescue of impaired LTP Hick et al., 2015
Bath application of recombinant APPsα (10 nm) No effect on basal synaptic transmission
APPsß Acute hippocampal slices of adult, APP/APLP2
conditional DKO mice
No rescue of impaired LTP Hick et al., 2015
Bath application of recombinant APPsß (50 nm) No effect on basal synaptic transmission
Aß1–15 Acute hippocampal slices of adult, c57bl6 mice fM Aß1–15 enhances PTP and LTP Lawrence et al., 2014
Bath application of aß1-15 (50 fM, 50 pM) pM Aß1–15 has no effect on PTP or LTP
Aη-α Acute hippocampal slices of adult Swiss-mice Unaltered baseline synaptic transmission Willem et al., 2015
Bath application of recombinant aη-α Significant reduction of hippocampal LTP
in vitro
Aη-ß Acute hippocampal slices of adult Swiss-mice Unaltered baseline synaptic transmission Willem et al., 2015
No effect on hippocampal LTP in vitro
Bath application of recombinant Aη-ß
APP-JCasp domain (NH2
terminal region of APP)
Intracellular delivered to presynaptic terminals of acute
hippocampal slices of adult WT and APP KO mice
Strong reduction in basal synaptic transmission
in WT, not in APP KO
Fanutza et al., 2015
Increases PPF and synaptic frequency
facilitation in WT, not in APP KO
Reduction of the rate of vesicle depletion
without affecting vesicle recycling
AICD Acute hippocampal slices of APP1CT15/APLP2-DM:
mice lacking the last 15 amino acids of APP including
YENPTY motif and APLP2
Decreased potentiation during PTP and LTP
Trend toward decreased L-LTP
Increased basal synaptic transmission
Unaltered PPF and STP
Klevanski et al., 2015
APP Murine OHCs of P0 APP-KO mice No difference in I/O characteristic Weyer et al., 2014
Unaltered short term plasticity
APLP1 APLP1-deficient adult male mice In vivo recording at PP-GC synapse: Vnencak et al., 2015
Enhanced excitatory transmission
Decreased paired pulse inhibition of population
spikes (decreased network inhibition)
Unchanged STP and LTP
(Continued)
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TABLE 1 | Continued
FL-APP or fragment Species/Methodic details Electrophysiological relevant observations References
APLP2 Acute hippocampal slices of young (1–2 months) and
aged (10–12 months) APLP2 deficient mice
Unchanged input-output characteristics across
ages to controls
Midthune et al., 2012
Unaffected PPF remains
No alterations in LTP
APP/APLP2 Acute hippocampal slices of conditional adult DKO mice Pronounced deficit in induction and
maintenance of LTP
Hick et al., 2015
Impaired PPF
Unaltered basal synaptic transmission
Unchanged spontaneous synaptic mEPSCS
in CA1
No differences in NMDA-r subunit composition
Acute hippocampal slices of 16–24 days old conventional
DKO mice
Increased PPF and synaptic frequency
facilitation
Decreased mEPSCs frequency and increased
MEPSC decay time
Fanutza et al., 2015
ADAM-10 (α-secretase) (1) Acute hippocampal slices of adult, female, conditional
adam-10 KO
(1) Unaltered basic synaptic transmission
impaired short-term synaptic plasticity strongly
impaired LTP
Prox et al., 2013
(2) In vivo hippocampal recordings in adult male CKO
mice
(2) Electrographic seizure in one of five mutants
FIGURE 1 | Proteolytic processing of APP. Full-length APP can be processed by α-, ß-, η-, and γ-secretases in three different pathways. The left panel illustrates
the η-secretase processing of APP. Initially η-secretase cleavage releases the soluble APPsη, while CTFη remains embedded in the membrane. It is further processed
by α- or ß-secretase at the extracellular side generating An-α or An-ß. Shedding of CTFη within the transmembrane domain by γ-secretase yields the APP intracellular
domain (AICD) containing the highly conserved interaction motif (YENPTY, yellow box) or the short extracellular peptides Aß seen in the amyloidogenic or p3 within the
non-amyloidogenic pathway. The non-amyloidogenic pathway depicted in the middle is driven by the α-secretase liberating APPsα in the extracellular space.
Subsequently processing of membrane tethered CTFα by γ-secretase generates the p3 peptide and cytoplasmic AICD. The right panel illustrates APP processing in
the amyloidogenic pathway by ß-secretase resulting initially in the release of the APPsß ectodomain. Following γ-secretase shedding of the membrane tethered CTFß
the Aß peptide is secreted along with AICD in the cytoplasm.
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FIGURE 2 | Role of the APP protein family at the synapse. (A) The extracellular domains of APP/APLPs mediate cell-cell adhesion in trans supporting synaptic
connectivity. APP and APLP2 are mainly located in the Golgi apparatus and trans Golgi network. When integrated in the plasma membrane, APP and APLP2 show
basal adhesive characteristics, while the proportion of plasma membrane APLP1 is higher and it’s insertion dynamic. (B) Homodimerized APP might function as a
cell-surface G-protein coupled receptor which is recognized by Aß and initiates signaling as well as neurotransmitter release by activation of calcium channels. Aß,
Aß1-15, and potential also APPsα induce an AChR-dependent signal facilitating glutamate release via an increase in presynaptic calcium concentration. APP and
APLP2 are mainly implicated in presynaptic function and their intracellular domains are associated with proteins of the synaptic vesicle release machinery regulating
the vesicle content in the presynaptic active zone. (C) High frequency stimulation increases APP ectodomain shedding that might be linked to the activation of
mGluRs or AChRs. High amounts of APPsα facilitate the function of NMDA-Rs by increasing the agonist D-serine or by induction of immediate early genes as well as
signaling pathways like that of CamKII to support synaptic plasticity.
measurements of murine organotypic hippocampal slice cultures
(OHCs) from APP-KO pups prepared at postnatal day zero.
No differences in the Input–Output characteristics and STP
of APP-KO in comparison to wild-type OHCs were observed
(Weyer et al., 2014). In agreement, the loss of APP does not
impair synaptic plasticity in the adult organism and thereby
APLP2 and maybe APLP1 are considered to perform redundant
functions, but fail to compensate for APP deficiency with
age.
APLP2-KO
The function of APLP2 in synaptic plasticity has also been
addressed in detail since this protein shares the highest degree
of sequence homology with APP within the gene family.
Furthermore, the spatial and temporal expression pattern of
APLP2 is highly reminiscent to that of APP (Wasco et al., 1993).
APP and APLP2 are ubiquitously expressed in the nervous tissue
and at the neuromuscular junction (NMJ, Slunt et al., 1994;
Lorent et al., 1995) as well as in pyramidal and GABAergic
neurons of the hippocampus and cortex (Wang et al., 2014; Hick
et al., 2015). In contrast to APP-KOmice, young and aged APLP2
single KOs behave like wild-type mice showing no impairments
in LTP, STP, PPF, or basal synaptic transmission (Weyer et al.,
2011; Midthune et al., 2012). These observations go in line with
normal learning and memory performance in cognitive tasks
like the Morris-Water-Maze (MWM) or the passive avoidance
test (Heber et al., 2000; Guo et al., 2012). The functional effects
are consistent with investigations of dendritic spine numbers at
excitatory neurons, reflecting the number of excitatory synapses.
Whereas, the spine density assessed in vivo was affected in
aged APP-KO animals, it was unaltered in APLP2-KO mice as
well as in APLP2 OHCs in vitro (Lee et al., 2010; Midthune
et al., 2012; Weyer et al., 2014). It seems likely that endogenous
APP is able to compensate for the genetic ablation of APLP2
with age, while vice versa APLP2 is incapable to compensate
the loss of APP in aged animals. This implicates that APP has
either different or dominant neuronal functions compared to
APLP2.
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BOX 1 | Term definitions.
Synaptic plasticity designates the activity-dependent alterations of the efficacy of synaptic transmission and changes in the structure as well as number of synaptic
connections whereby activity patterns are generated by experience. Synaptic connections build the contact sites between nerve cells and alterations at these contact
sites provide the basis to store memories and information within neuronal networks (Korte and Schmitz, 2016).
LTP—Long-term potentiation is defined as a persistent increase in synaptic strength lasting for at least 1 h (Bliss and Lomo, 1973). It consists of an induction
phase, including processes that trigger the alterations leading to the changes in synaptic efficacy followed by the expression or maintenance phase of LTP. LTP can
be divided in different types: LTP lasting from 1 to 3 h is independent of transcription and translation and named early or E-LTP; if it lasts longer than 3 h, it is generally
dependent on altered gene expression and referred to as late LTP (L-LTP, Bliss and Collingridge, 1993; Kandel, 2001).
LTD—Long-term depression is the counterpart of LTP and therefore defined as a persistent reduction in synaptic strength. LTD prevents excessive synaptic activity
(Korte and Schmitz, 2016).
STP—Short term synaptic plasticity is a form of synaptic plasticity that is NMDA-R dependent, but presynaptically expressed. It depends on the frequency of
induction as well as subsequent activity and lasts from ms to min (Zucker and Regehr, 2002; Volianskis and Jensen, 2003).
PPF—Paired-pulse facilitation is a NMDA receptor-independent form of short-term plasticity and a typical presynaptic phenomenon. The facilitation is caused in
the process of re-establishment of intracellular Ca2+ levels after repetitive Ca2+ influx into the presynaptic terminal. PPF can be investigated by applying two single
stimuli spaced by a defined time interval. Depending on the length of the Inter-Stimulus-Interval and type of stimulus used the second signal is facilitated or depressed
(Paired-pulse depression, PPD). At shorter ISIs of <20 ms PPD is observed whereas larger ISIs >20 ms lead to PPF (Zucker and Regehr, 2002).
Spine density—Spines are small membrane protrusions from dendrites often with a neck-head structure building the postsynaptic elements of glutamatergic
synapses (Korte and Schmitz, 2016). Their density can therefore be seen as correlate of the amount of excitatory synapses and often represents functional changes
in synaptic strength.
APLP1-KO
Despite the generation and first characterization of the
conventional APLP1-KOmouse in 2000 byHeber and colleagues,
the function of this homolog has been less attended in synaptic
plasticity Since APLP1 is the only APP family member with
restricted expression to the brain (Lorent et al., 1995; Thinakaran
and Koo, 2008; Klevanski et al., 2014), it is intriguing to
speculate that APLP1 has a unique neuronal role and therefore
might also be of particular importance for synaptic plasticity.
However, Heber et al. (2000) described only minor (if any)
distinct phenotypes of APLP1-KO. The ablation of the APLP1
gene function did not result in impaired cognitive behavioral
performance in the MWM task but rather. However, during
the behavioral paradigm it has been noted that depletion of
APLP1 resulted in an improvement of acquisition learning. The
in vivo analysis at the perforant path-granule cell synapse (PP-
DG) in young adult mice (16–20 weeks old) revealed unaltered
STP and LTP, associated to enhanced excitatory transmission
(Vnencak et al., 2015). The authors argued that maybe a larger
number of perforant path synapses or an increased synaptic
strength in APLP1-deficient mice may cause this enhancement,
but final clarification is missing. Furthermore, the paired-pulse-
inhibition (PPD) paradigm of the population spike points toward
decreased GABAergic network inhibition in APLP1-KOs, an
effect observed also for other APP-KO models.
ROLE OF THE APP PROTEIN FAMILY IN
SYNAPTIC INHIBITION
The hippocampus is comprised of 95% excitatory and 5%
inhibitory neurons, both expressing the APP family proteins
(Hick et al., 2015). It is well established that the GABAergic
system is especially important during the induction of LTP (Bliss
and Lomo, 1973) and that excitation and inhibition must be
tightly balanced for a well-coordinated network. This notion is
supported by the finding that the inhibition of GABAA receptors
facilitates LTP and leads to hyperexcitability causing epileptic
seizures (Gustafsson and Wigström, 1988; Casasola et al., 2004).
Hippocampal hyperactivity is a hallmark of neurological diseases
like mild cognitive (MCI, Bakker et al., 2012) and AD (Palop
et al., 2007). Several studies suggest that the hyperactivity is
caused by APP overexpression (Born et al., 2014) while others
assume Aß to be the trigger (Busche et al., 2008; Minkeviciene
et al., 2009). The APP family proteins seem to be closely involved
in regulating GABAergic transmission as both APLP1-KO and
aged APP-KO mice exhibit reduced GABAergic mediated PPD
responses (Seabrook et al., 1999; Vnencak et al., 2015) and
in addition increased susceptibility for kainite-induced seizures
(Steinbach et al., 1998). Moreover, supporting the role of
APP within the GABAergic network are the chronic reduction
of GABAA receptors and the lowered number of GABAB
autoreceptors mediating PPD of inhibition in the absence of
APP (Fitzjohn et al., 2000) as well as the identified interaction
of APP with GABAB receptors in vitro (Norstrom et al., 2010)
as well as recently in vivo (Schwenk et al., 2016). Like in
APP-KO, in mice expressing only the secreted APPsα on an
APLP2 deficient background (APPsa-DM; Weyer et al., 2011),
the neutralization of GABAA receptors by picrotoxin rescues
impaired LTP presumably due to a facilitation of postsynaptic
depolarization. Moreover, while addressing oscillatory activity by
recording local field potentials (LFPs) in the dorsal hippocampus
revealed normal theta- and gamma-frequency bands the coupling
of gamma amplitude to the theta phase was diminished in
around 9 months old APP-KO mice (Zhang et al., 2016). This
observation indicates the presence of alterations within the local
inhibitory networks (Zhang et al., 2016) thereby preventing a
coordinated neuronal communication. Investigations by Yang
et al. (2009) yielded that deletion of APP in hippocampal neurons
increased L-type voltage gated Ca2+ channel (LTCC) levels and
function underlying an altered GABAergic STP. Likewise, a
recent report implied APP possibly via the APPsα fragment to
stabilize Ca2+ homeostasis by regulating inhibition of LTCCs
(Hefter et al., 2016). Nevertheless, APLP1 deficiency causes no
LTP deficit even though GABAergic inhibition is affected in
APLP1-KO mice. The related proteins, APP and APLP2, might
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exhibit similar interactions at the presynaptic membrane and
thus possibly compensate for the functional loss of APLP1
at the postsynaptic density (PSD) during LTP induction and
maintenance.
APP AND APLP2 DOUBLE KO
The high content of APP and APLP2 especially in pyramidal cells
of the cortex and hippocampus (Lorent et al., 1995) and their
localization at synaptic sites (Laßek et al., 2013) suggest a role
in synaptic transmission and synaptic plasticity. To address the
function of these redundantly expressed proteins, combined KO
models are necessary. Unfortunately, APP and APLP2 double
KO (DKO) mice die perinatally (von Koch et al., 1997; Heber
et al., 2000) indicating an indispensable role for both these
proteins during development. The lethal phenotype of these
DKO mice is most likely due to important functions of APP
and APLP2 at the NMJ (Wang et al., 2005; Weyer et al.,
2011) and reviewed by Caldwell et al. (2013). Neuromuscular
transmission is severely impaired due to a reduced amount of
synaptic vesicles and their impaired release. While the Knock-
In of APPsα in the APP/APLP2-DKO mouse (APPsα-DM)
rescued the lethal phenotype it resulted in muscular weakness
and severe alterations in NMJ morphology (Ring et al., 2007).
While the above study indicated that at the NMJ of APP and
APLP2 DKO mice most alterations are found presynaptically,
the role of the APP family members and their fragments at
synapses within the CNS still remained open. The conditional
approach used by Hick et al. (2015) opened the possibility to
address the function of APP and APLP2 in the CNS leaving
the PNS unaffected. Crossing of APPflox/flox on an APLP2 null
background to NexCre-deleter mice generates viable double
mutants (cDKO). In these mice the depletion of APP is initiated
from embryonic stage 11.5 onwards in excitatory neurons of
the forebrain, while APLP2 is constitutively not expressed
allowing the investigation of neurodevelopmental effects. Young
adult mice show a pronounced deficit in LTP induction
and maintenance as well as impairments in PPF. Alterations
during the initial phase of LTP, the so-called post-tetanic
potentiation and also STP provided a hint toward an impaired
presynaptic function. In contrast, the functionality of the
postsynapse remained unaffected as basal synaptic transmission
was unaltered (Hick et al., 2015). Another study using young
conventional APP/APLP2 deficient mice (APP/APLP2-DKO,
surviving escape mutants) described increased PPF and synaptic
frequency facilitation (FF, Fanutza et al., 2015), supporting the
assumption that APP and APLP2 are involved in presynaptic
function.
PRESYNAPTIC FUNCTION OF APP FAMILY
PROTEINS
Short-term plasticity (STP) depends on the release probability of
synaptic vesicles, their recycling and content in the presynapse
as well as on the activity of calcium sensor kinases. APP and
APLP2 show a variety of possible interactions with the synaptic
vesicle release machinery: Biochemical approaches showed that
APP is associated with synaptic vesicle proteins (Del Prete
et al., 2014; Laßek et al., 2014) and that it can be cleaved
within vesicles by BACE-1 (Del Prete et al., 2014). Especially
the intracellular regions of APP, APLP2, and CTF-ß have been
shown to interact with presynaptic vesicle proteins like Rab,
AP-2 subunits, the Ca2+ sensors synaptotagmins, clathrin, and
complexin (Del Prete et al., 2014; Fanutza et al., 2015). Results
from APP-KO animals point toward a role of APP in controlling
synaptic vesicle protein content in the presynaptic active zone
as synaptophysin, synaptotagmin-1, and SV2A protein levels
are reduced in APP KO mice. In contrast, when beside APP
also APLP1 or APLP2 are gene targeted, the abundance of
synaptic vesicle proteins is increased (Laßek et al., 2014). The
increase in SV2A and synaptotagmin-1 has also been observed
in the conditional APP/APLP2 mutant mice generated by Hick
et al. (2015) and recently analyzed (Laßek et al., 2016). In that
study, Lassek and colleagues further show that APP deletion
disturbs Ca2+ homeostasis, due to a misregulation of calmodulin
and neuromodulin but not of the expression of CaMKII or
Ca2+ channels. APLP1 is also localized at the presynaptic active
zone (Laßek et al., 2016), but beside the function as mediator
of neuronal adhesion (Kaden et al., 2009; Mayer et al., 2016)
and its potential involvement in GABAergic neurotransmission
(Vnencak et al., 2015) no other role or interaction partners have
been attributed so far.
POSTSYNAPTIC FUNCTION OF APP
FAMILY PROTEINS
In addition to a possible function at the presynapse in the
developing and mature CNS, all APP family members have
been suggested to play a role at the postsynapse. In particular
an interaction with N-methyl-D-aspartate receptors (NMDA-
R) has been shown especially for the GluN1/GluN2A and
GluN1/GluN2B subunits (Cousins et al., 2015). APP, APLP1, and
APLP2 are further involved in the regulation of the cell surface
expression of NMDA-Rs thus controlling NMDA-R homeostasis
(Cousins et al., 2015).
Addressing the role of APP and APLP2 at the postsynapse
with the whole cell patch clamp method (measuring miniature
excitatory postsynaptic currents (mEPSCs) yielded conflicting
results. The study of Fanutza et al. (2015) using conventional
APP/APLP2 double mutants, described a decreased mEPSC
frequency and an increased mEPSC decay time leading to
the assumption of redundant mediated function of APP
and APLP2. In contrast, Hick et al. (2015) investigated a
conditional APP/APLP2 KO (cDKO) and found no alterations
in spontaneous synaptic mEPSCs and in their frequencies.
Moreover, the analysis of the NMDA-R subunit composition
further points toward unchanged postsynaptic transmission
in the cDKO mice (Hick et al., 2015). In this context it is
important to note that around 80% of the APLP2−/−APP−/−
mice die within the first weeks after birth and only 0.3%
survive until weaning (von Koch et al., 1997; Heber et al.,
2000). Therefore, the mice studied by Fanutza et al. (2015)
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were so called “escape-mutants” and their results need to be
interpreted with care. It might be that the surviving conventional
DKOs developed adaptation mechanisms e.g., an upregulation
of synaptic proteins accounts for these controversial results.
APLP1 is supposed to accumulate at the postsynapse (Kim
et al., 1995) and was also shown to regulate NMDA-R content
(Cousins et al., 2015). APLP1, like the other two family
members contains the highly conserved YENPTY interaction
motif and in thus able to initiate downstream signaling
cascades in the postsynaptic compartment supporting synaptic
plasticity (activation of intracellular signaling cascades and their
contribution to synaptic plasticity is discussed below).
PROTEOLYTICALLY GENERATED
PEPTIDES—APPSα, APPSß, Aß, AN-α,
AN-ß
Gene targeting of APP family members using single and double
mutants provided evidence about the possible involvement of
these proteins in synaptic plasticity, but it could not answer the
question of whether the observed effects arose from the action
of the full-length proteins or from the absence of their secreted
fragment(s).
Evidence pointing to a role of APP fragments in processes
of synaptic plasticity arose from the observation that APP
processing by α- and ß-secretase is activity-dependent (Nitsch
et al., 1993; Fazeli et al., 1994; Kamenetz et al., 2003;
Gakhar-Koppole et al., 2008) and can thus be potentiated by
neuronal depolarization or high frequency stimulation (HFS).
Consequently, the released domains may be especially involved
during processes of synaptic activity.
Depending on their site of release, extra- and/or
intracellularly, they might have functions as signaling molecules
or initiate signaling by binding to different types of receptors.
Proteolytic processing of APP is depicted in Figure 1 and was
shown to be similar for APLP1 and APLP2 except for the release
of Aß as its coding sequence is absent in the APP homologs
(Eggert et al., 2004; Walsh et al., 2007). The current view allows
differentiation between three different pathways initiated by the
α-, ß-, or η-secretase (see Figure 1). In the non-amyloidogenic
pathway the α-secretase cuts within the Aβ domain liberating the
large APPsα ectodomain and a membrane-anchored C-terminal
fragment α (CTF α). The latter is further cut by the γ-secretase
releasing the p3 fragment extracellularly and the remaining
APP intracellular domain (AICD) into the cytoplasm. The
amyloidogenic processing by the ß-secretase yields the APPsß
ectodomain and the membrane-tethered CTF ß. Afterwards the
activity of the γ-secretase generates the AICD peptide along
with Aß. Recently Willem et al. (2015) identified a η-secretase
cleavage site in the extracellular domain of APP releasing a short
extracellular APPsη ectodomain. Subsequent processing of the
remaining membrane anchored CTF η by the α- or ß-secretase
generates two new peptides, Aη-α and Aη-ß (Willem et al.,
2015). Importantly, APP processing is not restricted to the
plasma membrane, but was also shown to occur within synaptic
vesicles (Del Prete et al., 2014).
APPSα PROMOTES SYNAPTIC
PLASTICITY
Numerous studies showed that the α-secretase released
ectodomain APPsα exerts a role in neuroprotection, synaptic
plasticity, and within neuronal networks (Ring et al., 2007;
Weyer et al., 2011; Kögel et al., 2012). The acute synaptic
function of endogenous APPsα in the adult brain was shown
by using APP/APLP2 cDKO mice (Hick et al., 2015). One hour
incubation with 10 nM recombinant APPsα peptide (recAPPsα)
rescued the severe LTP deficit in acute slices of the mutants
indicating that the soluble ectodomain acts on a rapid time-scale.
These results were in line with previous findings of Taylor et al.
(2008) reporting that intrahippocampal infusion of recAPPsα
in the dentate gyrus (DG) of anesthetized rats enhances LTP
recorded at the PP-DG pathway in vivo. Moreover, a recent
study showed that recAPPsα is able to rescue age-dependent LTP
deficits in vitro (Moreno et al., 2015). In addition, we showed that
virus driven long-term expression of APPsα restores impaired
synaptic plasticity in a mouse model of AD (Fol et al., 2016). It
is by now not clear how APPsα mediates the rescue and which
receptor might be activated. Overall there is good evidence for
a prominent role of APPsα at the postsynapse, in particular by
influencing NMDA-R function and synaptodendritic protein
synthesis (Taylor et al., 2008; Claasen et al., 2009).
MODULATION OF POSTSYNAPTIC
FUNCTION BY APPSα
One possible mechanism of APPsα action at synapses might be
the facilitation of evoked NMDA-R currents at the postsynapse
as shown in the study of Taylor et al. (2008). These results
were confirmed by acute application of recAPPsα on acute slices
of APP/APLP2 cDKO mice or aged rats restoring the LTP
induction deficit and highlighting that APPsαmodulates synaptic
plasticity and regulates early events of the LTP processes (Hick
et al., 2015; Moreno et al., 2015). Both studies further report
that exogenous applied APPsα does not affect basal synaptic
transmission or glutamate release. NMDA-Rs may stimulate α-
secretase cleavage of APP during high-frequency stimulation
(HFS) or HFS activates metabotropic glutamate (mGluRs) or
muscarinic acetylcholine receptors (mAChRs) to promote APPsα
release. Notably, the processing must be tightly regulated as
high APPsα concentrations reduce LTP induction by activation
of inhibitory signaling pathways (Taylor et al., 2008). The
concentration dependent action of APPsα to increase NMDA-
R currents could further be linked to D-serine availability at
the synapse (Moreno et al., 2015). D-serine is the main co-
agonist required for NMDA-R activation (for details see review
Billard, 2012) and APPsα stimulates it’s production and release.
A recent study further showed that APP deficiency is linked to
alterations in D-serine levels accompanied by impaired structural
plasticity of dendritic spines (Zou et al., 2016). Facilitation of
LTP expression by APPsα might also be mediated through
the induction of a subset of plasticity-associated immediate
early genes (Ryan et al., 2013), with de novo protein synthesis
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taking place in synaptoneurosomes mainly by activation of
protein kinase G (Claasen et al., 2009). Among APPsα activated
signaling cascades are furthermore the phosphatidylinositol-3-
kinase (PI(3)K)-Akt kinase signaling pathway (Cheng et al., 2002;
Milosch et al., 2014) and the mitogen-activated protein (MAP)
kinase signaling pathway (Greenberg et al., 1995; Cheng et al.,
2002).
Taken together, APPsα initiates several intracellular signaling
cascades to support synaptic activity with an impact on NMDA-
R currents, but still the APPsα-specific receptor triggering
the effect on NMDA-Rs remains so far elusive. At least the
experiments performed by Reinhard et al. (2013) could show that
APPsα binding to a cell surface receptor involves two different
subdomains. The N-terminal growth factor like domain (GFLD)
of APPsαmediates the binding of protein and receptor, while the
E2 domain interacts with membrane-anchored heparin sulfate
proteoglycans (HSPG) and thus enhances the affinity to the
APPsα-receptor. Among the potential receptors for which an
interaction with the APP ectodomain is suggested are the low-
density lipoprotein receptor-related protein (LRP1, Hoffmann
et al., 1999; Goto and Tanzi, 2002), the sortilin-related receptor
SORLA (Andersen et al., 2006; Hartl et al., 2013), Nogo-66 (Park
et al., 2006), and the p75 neurotrophin receptor (Hasebe et al.,
2013).
INHIBITION OF APPSα MEDIATED
FUNCTIONS
In-line with the results following exogenous application of APPsα
on LTP in vitro and in vivo are the opposite effects observed
after α-secretase inhibition (which leads to a reduction in
APPsα production). The conditional KO of the major α-secretase
ADAM-10 resulted in strongly impaired LTP and altered STP
(Prox et al., 2013). Within this study no differences in basic
synaptic transmission were found. Interestingly, hippocampal
network activity recorded in vivo in the CA1 region of the
hippocampus of ADAM-10 cDKO mice was severely impaired
and 20% of the animals showed electrographic seizures (Prox
et al., 2013). A modulatory role for APPsα on network activity
in the hippocampus and cortex has further been observed with
regard to aging by Sánchez-Alavez et al. (2007) which recorded
electroencephalographic activity. In addition, the key role of
APPsα and APLP2sα for LTP induction and maintenance was
shown by experiments using the ADAM-10 inhibitor in OHCs
(Weyer et al., 2011) or by in vivo LTP recordings in the dentate
gyrus after infusion of the α-secretase inhibitor TAPI-1 (Taylor
et al., 2008). Due to the lack of ADAM-10 or its inhibition,
APP processing by the ß-secretase is favored resulting in higher
amounts of Aß peptides and APPsß which may further impair
LTP, especially at nano- to micromolar levels see reviewWang H.
et al. (2012).
APPSß DOES NOT MODULATE SYNAPTIC
FUNCTION
Only a few studies addressed the physiological action of the
ß-secretase which leads to the release of the ectodomain APPsß
(see Figure 1). APPsß is only 16 amino acids shorter than APPsα,
but it is not as neuroprotective as APPsα. This was demonstrated
by the Knock-In of the two soluble domains in the perinatal
APP/APLP2 DKO mutant model. Only APPsα+/+APLP2−/−,
but not APPsß+/+APLP2−/− mice were viable (Li et al., 2010;
Weyer et al., 2011). With regard to synaptic plasticity, APPsß
cannot restore the LTP defect of APP/APLP2 cDKO mice (Hick
et al., 2015) and does not facilitate LTP recorded in vivo within
the DG of rats (Taylor et al., 2008). APPsß was further shown to
have no influence on synaptic protein synthesis (Claasen et al.,
2009). Consistent with the functional readout on synapses, Tyan
et al. (2012) showed that only APPsα but not APPsβ partially
rescued defects in dendritic spine number and morphology of
primary hippocampal neurons from APP-KO mice.
Aß DOMINANTLY ACTS AT THE
PRESYNAPSE
At physiological, picomolar concentrations Aß was shown to
modulate presynaptic vesicle release (Puzzo et al., 2008; Abramov
et al., 2009; Wang H. et al., 2012). It functions via binding
to presynaptic APP homodimers (Fogel et al., 2014) or by
activating α7-nAChRs (Tong et al., 2011). The study by Lawrence
et al. (2014) highlighted that the N-terminal domain of Aß
contains this agonist-like activity of the Aß peptide. It was
further suggested that successive α- and ß-secretase activity will
release the short functional domain, named Aß1–15 (or Aß1–
16, Portelius et al., 2011). With regard to synaptic plasticity,
Aß1–15 significantly enhances PTP and LTP without altering
baseline synaptic transmission at femtomolar concentrations,
while higher amounts had no effect on hippocampal LTP
(Lawrence et al., 2014). During LTD, Aß was shown to have a
facilitating role through mGluR and NMDA-R due to the altered
glutamate recycling at synapses (Li et al., 2009; Chen et al., 2013).
The pathological effects of Aß, especially Aß42, are discussed
in detail elsewhere (Mucke and Selkoe, 2012; Wang H. et al.,
2012; Ripoli et al., 2014; Salgado-Puga and Pena-Ortega, 2015)
We only want to mention that under pathological conditions
Aß has the opposite effects on synaptic plasticity: it facilitates
LTD, depresses LTP, causes dendritic spine loss and leads to
hippocampal hyperactivity (Selkoe, 2002; Busche et al., 2008;
Shankar et al., 2008; Mucke and Selkoe, 2012; Fol et al., 2016).
AN-α AND AN-ß, THE NEW PLAYERS IN
THE FIELD
The recently identified η-secretase releases a short extracellular
APP-η ectodomain (Willem et al., 2015). The CTFη cleavage
product remains anchored to the plasma membrane and
subsequently is further processed by α- or ß- secretases to
produce two small peptides, Aη-α and Aη-ß (see Figure 1;
Willem et al., 2015). Willem and colleagues assessed the synaptic
function of these peptides by measuring LTP in vitro. While
both peptides had no influence on baseline synaptic transmission,
hippocampal LTP was severely impaired by Aη-α but not by Aη-
ß. The only structural difference between the two molecules is
a C-terminal elongation of the Aη-α peptide by 16 additional
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amino acids (Figure 1). Interestingly, the same 16 amino acids
are also present at the C-terminus of the APPsα fragment
and, similar to Aη-ß, are lacking in the truncated APPsß form
(Figure 1). This short peptide sequence contains a predicted
neuroprotective domain and a heparin binding site (Furukawa
et al., 1996). Indeed, neuroprotective properties have been
reported for the APPsα peptide. However, and in contradiction
to a favorable cellular function of this amino acid sequence, it
has been found that Aη-α mediates neurotoxic effects (Willem
et al., 2015). The adverse action of Aη-α was also observed
by in vivo Ca2+ imaging experiments performed in the study
of Willem et al. (2015) in which Aη-α strongly suppressed the
activity of hippocampal neurons. In line with these findings are
the observations for both ß-derived peptides. It seems unlikely
that these fragments are involved in synaptic plasticity since
both Aη-ß and APPsß lacked any modulatory effects on synaptic
transmission when bath-applied to acute-hippocampal slices of
APP/APLP2 cDKOmice at CA3-CA1 synapses (Hick et al., 2015)
or when added during mossy fiber LTP recordings (Taylor et al.,
2008). The different modes of action might be a consequence of a
conformational change caused by the 16 additional amino acids
at the carboxy-terminus of the Aη-α/APPsα cleavage products
and/or by specific post-translational modifications (PTMs) like
glycosylation or phosphorylation (Walter and Haass, 2000). In
the study of Willem et al. (2015) Aη-α conditioned medium or
100 nM synthetic Aη-α showed a reduction in LTP, while only
lower concentrations of 1–11 nM recombinant APPsα increased
LTP. Moreover, the application of higher APPsα amounts had no
effect or resulted even in reduced LTP (Taylor et al., 2008; Hick
et al., 2015; Moreno et al., 2015). It would be interesting to know
if APPsα can additionally be cleaved by η-secretase and if the
released Aη-α could act as a co-player for Aß or APPsα andwould
therefore provide a modulatory mechanism.
KNOCK-IN OF APPSα, APPSß, AND THE
APP INTRACELLULAR DOMAIN (AICD)
Beside the acute application of APP functional domains as
peptides, gene targeting allows their re-introduction on APP
or APLP2 null backgrounds. These conditional approaches or
Knock-In (KI) mice opened the possibility of the functional
characterization of the APP/APLP proteins during development
as the constitutive triple KO and nearly all DKOs are embryonic
lethal (von Koch et al., 1997; Heber et al., 2000). The study
of Ring et al. (2007) analyzed the role of two APP functional
domains by generating C-terminally truncated KI alleles of
APP. APPsα-KI mice produce only APPsα, whereas APP1CT15-
KI mice lack the last 15 amino acids, including the highly
conserved YENPTY motif. The phenotypes of both KI lines
were similar to WT littermates. LTP as well as learning and
memory assessed in behavioral tasks were normal presumably
due to the constitutive expression of APLP2. The subsequent
combination of both KImice with APLP2 null mutants generated
partially viable offsprings, whereas APPsβ-DM mice die (Li
et al., 2010). APPsα-DMs were characterized in detail by Weyer
et al. (2011) and APP1CT15-DMs in the study of Klevanski
et al. (2015). Both DM strains display alterations at PNS
and CNS synapses. The mice suffer of muscular weakness
due to altered morphology of the NMJ synapse and impaired
transmitter release. Still, the APPsα-DMs reveal more severe
electrophysiological impairments at the NMJ by additional
reduced quantal content and alterations in the frequency
of miniature endplate potentials (MEPP) compared to single
mutants investigated by Ring et al. (2007). Hence different motifs
account for a normal physiological function in the DMs. With
regard to the CNS, both DMs are an impaired induction and
maintenance of LTP paralleled by severely altered hippocampus-
dependent behavior. STP between CA3/CA1 pyramidal cells
was unchanged, while only APP1CT15-DMs have altered
postsynaptic properties and a trend toward defective protein-
synthesis dependent Late-LTP.
AICD Is Crucial at Both Sites of the
Synapse
The sole expression of AICD on an APP/APLP2 deficient
background revealed alterations in synaptic plasticity. This
might be a consequence of the abolished interaction of the
intracellular domain with several adaptor proteins (Klevanski
et al., 2015). For instance, APP interaction partners like
Dab1, Shc, Grb, and Mint/X11 proteins mediate not only
clathrin-mediated endocytosis of APP, but are also involved
in the translocation of APP to the cell-surface (Aydin et al.,
2012; van der Kant and Goldstein, 2015). Of particular
importance might be the interaction with the adapter protein
family FE65.I Interestingly FE65/FE65L1double deficient mice
show a similar phenotype of cortical dysplasia as APP triple
KO animals (Guénette et al., 2006). The FE65 proteins co-
localize with APP in the ER and Golgi and facilitate the
translocation of the precursor protein to the cell surface (Sabo
et al., 1999). In addition, these proteins also regulate the
shuttling of a multimeric complex of AICD/FE65/Tip60 into
the nucleus to regulate gene transcription (Cao and Südhof,
2001). Long-lasting strengthening of synaptic transmission is
impaired in APP1CT15-DMs perhaps by impaired FE65/AICD
mediated postsynaptic transcriptional activity (Klevanski et al.,
2015). Interestingly, the analysis of FE65-KO, FE65L1-KO, and
FE65/FE65L1-DKO mice revealed similar CNS phenotypes with
impairments in LTP and dysfunctions in hippocampal learning
tasks in double transgenic animals (Strecker et al., 2016).
Accordingly, the APP-FE65 interaction might be crucial for
synaptic function, but also for precise ectodomain shedding. In
APP1CT15-DMsmice, processing of APP via the amyloidogenic
pathway is heavily impaired (Klevanski et al., 2015). That
might have a positive effect with regard to Aß accumulation
but also a negative outcome since picomolar amounts of Aß
positively regulate the presynaptic vesicle release probability and
facilitate learning and LTP in the hippocampal CA1 region
by activating α7-nAChRs (reviewed by Wang H. et al., 2012).
Collectively, these studies highlight an essential function for the
15 C-terminal amino acids including the YENPTY motif for
transmembrane signaling and the ectodomain APPsα for proper
synapse function.
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CONCLUSION
The majority of experimental data provided so far indicate a
requirement for APP and APLP2 in synaptic plasticity which is
in particular mediated by their proteolytic derived domains. The
diverse functions of the APP protein family during either pre-
or postsynaptically initiated processes of synaptic plasticity and
under basal conditions are summarized in Figure 2. According to
this model, APP full length proteins mediate stability of synaptic
structures by their cell adhesion properties when integrated into
the plasma membrane (Kaden et al., 2009; Baumkötter et al.,
2012) and thus maintain appropriate spine numbers, especially
via the APPsα domain (Tyan et al., 2012; Weyer et al., 2014).
The insertion of full-length proteins is regulated by electrical
activity or gradients of ions like zinc. The APLP1 protein shows
the highest presence at the cell surface among all APP protein
family members (Kaden et al., 2009; Mayer et al., 2016). As
indicated Figure 2B depicts the APP protein family function
at the presynaptic site, where the Aß, Aß-15 and possibly the
APPsα domain interfere with glutamate release by activating
nAChRs and enhancing intracellular Ca2+ levels (Puzzo et al.,
2008; Wang Z. et al., 2012; Lawrence et al., 2014). It is further
hypothesized that homodimerized APP acts as a G-Protein
coupled receptor which is activated by Aß and might be involved
in neurotransmitter release following enhanced Ca2+ influx.
Especially the intracellular domains of APP and APLP2 seem
to be associated with proteins of the synaptic vesicle release
machinery regulating the molecular composition of synaptic
vesicles at the presynaptic active zone (Del Prete et al., 2014;
Fanutza et al., 2015; Laßek et al., 2015). At the postsynaptic
compartment (Figure 2C) patterns of synaptic activity modulate
APP family protein processing. HFS enhances the amount of
secreted APPsα possibly linked to mGluRs or AChRs activation
(Nitsch et al., 1992, 1997). Released APPsα was shown to
facilitate NMDA-R currents (Taylor et al., 2008; Weyer et al.,
2011) by increasing the NMDA-R agonist D-serine (Moreno
et al., 2015) or by up-regulating signaling cascades downstream
of NMDA-Rs- promoting synaptic plasticity like the CamKII
pathway (Claasen et al., 2009) or by inducing the expression of
immediate early genes involved in synaptic plasticity (Ryan et al.,
2013). In this regard only APPsα was shown to have trophic
functions while APPsß mediates neither positive nor negative
effects with respect to baseline synaptic function or synaptic
plasticity (Taylor et al., 2008; Hick et al., 2015). Several lines of
evidence indicate that under physiological conditions structural
and functional synaptic modulation is mediated by APPsα. What
still needs to be investigated, however, is the mechanism by which
APPsα exerts its trophic action, particularly which receptormight
be activated and if the recently discovered Aη peptides might
function as regulators of APPsαmediated synaptic plasticity and
homeostasis. Identifying the cellular site of η-secretase cleavage
within neurons and answering whether the secretion of Aη
peptides is linked to neuronal activity will reveal the roles of the
peptides in processes of synaptic plasticity.
Overall elucidating the physiological function of APP family
members and fragments is an important step to understand brain
function as well as brain dysfunction, also with respect to a
possible treatment of neurodegenerative disorders like AD. It is
important to acknowledge, that rational therapeutic approaches
need to take into account the functional role of disease associated
proteins.
AUTHOR CONTRIBUTIONS
SL: wrote the review and prepared the figures. MK: designed the
review and wrote the paper.
FUNDING
This work was supported by the Deutsche
Forschungsgemeinschaft Grants (KO 1674/3-1, 3-2) to MK.
REFERENCES
Abramov, E., Dolev, I., Fogel, H., Ciccotosto, G. D., Ruff, E., and Slutsky, I.
(2009). Amyloid-β as a positive endogenous regulator of release probability
at hippocampal synapses. Nat. Neurosci. 12, 1567–1576. doi: 10.1038/
nn.2433
Andersen, O. M., Schmidt, V., Spoelgen, R., Gliemann, J., Behlke, J., Galatis, D.,
et al. (2006). Molecular dissection of the interaction between amyloid precursor
protein and its neuronal trafficking receptor SorLA/LR11. Biochemistry 45,
2618–2628. doi: 10.1021/bi052120v
Aydin, D., Weyer, S. W., and Müller, U. C. (2012). Functions of the APP gene
family in the nervous system: insights frommouse models. Exp. Brain Res. 217,
423–434. doi: 10.1007/s00221-011-2861-2
Bakker, A., Krauss, G. L., Albert, M. S., Speck, C. L., Jones, L. R., Stark,
C. E., et al. (2012). Reduction of hippocampal hyperactivity improves
cognition in amnestic mild cognitive impairment. Neuron 74, 467–474.
doi: 10.1016/j.neuron.2012.03.023
Baumkötter, F., Schmidt, N., Vargas, C., Schilling, S., Weber, R., Wagner,
K., et al. (2014). Amyloid precursor protein dimerization and
synaptogenic function depend on copper binding to the growth factor-
like domain. J. Neurosci. 34, 11159–11172. doi: 10.1523/JNEUROSCI.0180-
14.2014
Baumkötter, F., Wagner, K., Eggert, S., Wild, K., and Kins, S. (2012). Structural
aspects and physiological consequences of APP/APLP trans-dimerization. Exp.
Brain Res. 217, 389–395. doi: 10.1007/s00221-011-2878-6
Bendotti, C., Forloni, G. L., Morgan, R. A., O’Hara, B. F., Oster-Granite, M. L.,
Reeves, R. H., et al. (1988). Neuroanatomical localization and quantification
of amyloid precursor protein mRNA by in situ hybridization in the brains
of normal, aneuploid, and lesioned mice. Proc. Natl. Acad. Sci. U.S.A. 85,
3628–3632. doi: 10.1073/pnas.85.10.3628
Billard, J. M. (2012). D-Amino acids in brain neurotransmission and synaptic
plasticity. Amino Acids 43, 1851–1860. doi: 10.1007/s00726-012-1346-3
Bliss, T. V., and Collingridge, G. L. (1993). A synaptic model of memory: long-term
potentiation in the hippocampus. Nature 361, 31–39. doi: 10.1038/361031a0
Bliss, T. V., and Lomo, T. (1973). Long-lasting potentiation of
synaptic transmission in the dentate area of the anaesthetized rabbit
following stimulation of the perforant path. J. Physiol. 232, 331–356.
doi: 10.1113/jphysiol.1973.sp010273
Born, H. A., Kim, J. Y., Savjani, R. R., Das, P., Dabaghian, Y. A., Guo, Q., et al.
(2014). Genetic suppression of transgenic APP rescues Hypersynchronous
network activity in a mouse model of Alzeimer’s disease. J. Neurosci. 34,
3826–3840. doi: 10.1523/JNEUROSCI.5171-13.2014
Busche, M. A., Eichhoff, G., Adelsberger, H., Abramowski, D., Wiederhold, K.
H., Haass, C., et al. (2008). Clusters of hyperactive neurons near amyloid
Frontiers in Molecular Neuroscience | www.frontiersin.org 11 January 2017 | Volume 9 | Article 161
Ludewig and Korte Role of APP in Synaptic Plasticity
plaques in a mouse model of Alzheimer’s disease. Science 321, 1686–1689.
doi: 10.1126/science.1162844
Caldwell, J. H., Klevanski, M., Saar, M., and Müller, U. C. (2013). Roles of the
amyloid precursor protein family in the peripheral nervous system.Mech. Dev.
130, 433–446. doi: 10.1016/j.mod.2012.11.001
Cao, X., and Südhof, T. C. (2001). A transcriptionally [correction of
transcriptively] active complex of APP with Fe65 and histone acetyltransferase
Tip60. Science 293, 115–120. doi: 10.1126/science.1058783
Casasola, C., Montiel, T., Calixto, E., and Brailowsky, S. (2004). Hyperexcitability
induced by GABA withdrawal facilitates hippocampal long-term potentiation.
Neuroscience 126, 163–171. doi: 10.1016/j.neuroscience.2004.03.029
Chen, X., Lin, R., Chang, L., Xu, S., Wei, X., Zhang, J., et al. (2013).
Enhancement of long-term depression by soluble amyloid α protein in rat
hippocampus is mediated by metabotropic glutamate receptor and involves
activation of p38MAPK, STEP, and caspase-3. Neuroscience 253, 435–443.
doi: 10.1016/j.neuroscience.2013.08.054
Cheng, G., Yu, Z., Zhou, D., and Mattson, M. P. (2002). Phosphatidylinositol-
3-kinase-Akt kinase and p42/p44 mitogen-activated protein kinases mediate
neurotrophic and excitoprotective actions of a secreted form of amyloid
precursor protein. Exp. Neurol. 175, 407–414. doi: 10.1006/exnr.2002.7920
Claasen, A. M., Guévremont, D., Mason-Parker, S. E., Bourne, K., Tate, W.
P., Abraham, W. C., et al. (2009). Secreted amyloid precursor protein-
α upregulates synaptic protein synthesis by a protein kinase G-dependent
mechanism. Neurosci. Lett. 460, 92–96. doi: 10.1016/j.neulet.2009.05.040
Cousins, S. L., Dai, W., and Stephenson, F. A. (2015). APLP1 and APLP2, members
of the APP family of proteins, behave similarly to APP in that they associate
with NMDA receptors and enhance NMDA receptor surface expression. J.
Neurochem. 133, 879–885. doi: 10.1111/jnc.13063
Del Prete, D., Lombino, F., Liu, X., and D’Adamio, L. (2014). APP is cleaved by
Bace1 in pre-synaptic vesicles and establishes a pre-synaptic interactome, via
its intracellular domain, with molecular complexes that regulate pre-synaptic
vesicles functions. PLoS ONE 9:e108576. doi: 10.1371/journal.pone.0108576
Dyrks, T., Weidemann, A., Multhaup, G., Salbaum, J. M., Lemaire, H. G., Kang, J.,
et al. (1988). Identification, transmembrane orientation and biogenesis of the
amyloid A4 precursor of Alzheimer’s disease. EMBO J. 7, 949–957.
Eggert, S., Paliga, K., Soba, P., Evin, G., Masters, C. L., Weidemann, A., et al.
(2004). The proteolytic processing of the amyloid precursor protein gene
family members APLP-1 and APLP-2 involves α-, β-, γ-, and ǫ-like cleavages:
modulation of APLP-1 processing by n-glycosylation. J. Biol. Chem. 279,
18146–18156. doi: 10.1074/jbc.M311601200
Fanutza, T., Del Prete, D., Ford, M. J., Castillo, P. E., and D’Adamio, L.
(2015). APP and APLP2 interact with the synaptic release machinery
and facilitate transmitter release at hippocampal synapses. Elife 4:e09743.
doi: 10.7554/eLife.09743
Fazeli, M. S., Breen, K., Errington, M. L., and Bliss, T. V. (1994). Increase in
extracellular NCAM and amyloid precursor protein following induction of
long-term potentiation in the dentate gyrus of anaesthetized rats.Neurosci. Lett.
169, 77–80. doi: 10.1016/0304-3940(94)90360-3
Fitzjohn, S. M., Morton, R. A., Kuenzi, F., Davies, C. H., Seabrook, G. R.,
and Collingridge, G. L. (2000). Similar levels of long-term potentiation in
amyloid precursor protein -null and wild-type mice in the CA1 region of
picrotoxin treated slices.Neurosci. Lett. 288, 9–12. doi: 10.1016/S0304-3940(00)
01204-0
Fogel, H., Frere, S., Segev, O., Bharill, S., Shapira, I., Gazit, N., et al. (2014). APP
homodimers transduce an amyloid-α-mediated increase in release probability
at excitatory synapses. Cell Rep. 7, 1560–1576. doi: 10.1016/j.celrep.2014.04.024
Fol, R., Braudeau, J., Ludewig, S., Abel, T., Weyer, S. W., Roederer, J.-
P., et al. (2016). Viral gene transfer of APPsα rescues synaptic failure
in an Alzheimer’s disease mouse model. Acta Neuropathol. 131, 247–266.
doi: 10.1007/s00401-015-1498-9
Furukawa, K., Sopher, B. L., Rydel, R. E., Begley, J. G., Pham, D. G.,
Martin, G. M., et al. (1996). Increased activity-regulating and neuroprotective
efficacy of α-secretase-derived secreted amyloid precursor protein conferred
by a C-terminal heparin-binding domain. J. Neurochem. 67, 1882–1896.
doi: 10.1046/j.1471-4159.1996.67051882.x
Gakhar-Koppole, N., Hundeshagen, P., Mandl, C., Weyer, S. W., Allinquant,
B., Müller, U., et al. (2008). Activity requires soluble amyloid precursor
protein α to promote neurite outgrowth in neural stem cell-derived neurons
via activation of the MAPK pathway. Eur. J. Neurosci. 28, 871–882.
doi: 10.1111/j.1460-9568.2008.06398.x
Goto, J. J., and Tanzi, R. E. (2002). The role of the low-density lipoprotein
receptor-related protein (LRP1) in Alzheimer’s Aβ generation: development of
a cell-based model system. J. Mol. Neurosci. 19, 37–41. doi: 10.1007/s12031-
002-0008-4
Greenberg, S. M., Qiu, W. Q., Selkoe, D. J., Ben-Itzhak, A., and Kosik,
K. S. (1995). Amino-terminal region of the β-amyloid precursor protein
activates mitogen-activated protein kinase. Neurosci. Lett. 198, 52–56.
doi: 10.1016/0304-3940(95)11944-R
Guénette, S., Chang, Y., Hiesberger, T., Richardson, J. A., Eckman, C. B.,
Eckman, E. A., et al. (2006). Essential roles for the FE65 amyloid precursor
protein-interacting proteins in brain development. EMBO J. 25, 420–431.
doi: 10.1038/sj.emboj.7600926
Guo, Q., Wang, Z., Li, H., Wiese, M., and Zheng, H. (2012). APP physiological and
pathophysiological functions: insights from animal models. Cell Res. 22, 78–89.
doi: 10.1038/cr.2011.116
Gustafsson, B., and Wigström, H. (1988). Physiological mechanisms
underlying long-term potentiation. Trends Neurosci. 11, 156–162.
doi: 10.1016/0166-2236(88)90142-7
Hartl, D., Klatt, S., Roch, M., Konthur, Z., Klose, J., Willnow, T. E., et al. (2013).
Soluble α-APP (sAPPα) Regulates CDK5 expression and activity in neurons.
PLoS ONE 8:e65920. doi: 10.1371/journal.pone.0065920
Hasebe, N., Fujita, Y., Ueno, M., Yoshimura, K., Fujino, Y., and Yamashita,
T. (2013). Soluble α-amyloid precursor protein α binds to p75
neurotrophin receptor to promote neurite outgrowth. PLoS ONE 8:e82321.
doi: 10.1371/journal.pone.0082321
Heber, S., Herms, J., Gajic, V., Hainfellner, J., Aguzzi, A., Rülicke, T., et al.
(2000). Mice with combined gene knock-outs reveal essential and partially
redundant functions of amyloid precursor protein family members. J. Neurosci.
20, 7951–7963.
Hefter, D., Kaiser, M., Weyer, S. W., Papageorgiou, I. E., Both, M., Kann, O.,
et al. (2016). Amyloid precursor protein protects neuronal network function
after hypoxia via control of voltage-gated calcium channels. J. Neurosci. 36,
8356–8371. doi: 10.1523/JNEUROSCI.4130-15.2016
Hick, M., Herrmann, U., Weyer, S. W., Mallm, J. P., Tschape, J. A., Borgers,
M., et al. (2015). Acute function of secreted amyloid precursor protein
fragment APPsα in synaptic plasticity. Acta Neuropathol. 129, 21–37.
doi: 10.1007/s00401-014-1368-x
Hoffmann, J., Pietrzik, C. U., Kummer, M. P., Twiesselmann, C., Bauer, C.,
and Herzog, V. (1999). Binding and selective detection of the secretory
N-terminal domain of the Alzheimer amyloid precursor protein on cell
surfaces. J. Histochem. Cytochem. 47, 373–382. doi: 10.1177/0022155499047
00311
Isbert, S., Wagner, K., Eggert, S., Schweitzer, A., Multhaup, G., Weggen, S.,
et al. (2012). APP dimer formation is initiated in the endoplasmic reticulum
and differs between APP isoforms. Cell. Mol. Life Sci. 69, 1353–1375.
doi: 10.1007/s00018-011-0882-4
Jacobsen, K. T., and Iverfeldt, K. (2009). Amyloid precursor protein and its
homologues: a family of proteolysis-dependent receptors. Cell. Mol. Life Sci.
66, 2299–2318. doi: 10.1007/s00018-009-0020-8
Kaden, D., Voigt, P., Munter, L. M., Bobowski, K. D., Schaefer, M., and
Multhaup, G. (2009). Subcellular localization and dimerization of APLP1
are strikingly different from APP and APLP2. J. Cell Sci. 122, 368–377.
doi: 10.1242/jcs.034058
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T.,
et al. (2003). APP processing and synaptic function. Neuron 37, 925–937.
doi: 10.1016/S0896-6273(03)00124-7
Kandel, E. R. (2001). Themolecular biology of memory storage: a dialogue between
genes and synapses. Science 294, 1030–1038. doi: 10.1126/science.1067020
Kim, T. W., Wu, K., Xu, J. L., McAuliffe, G., Tanzi, R. E., Wasco, W., et al.
(1995). Selective localization of amyloid precursor-like protein 1 in the
cerebral cortex postsynaptic density. Brain Res. Mol. Brain Res. 32, 36–44.
doi: 10.1016/0169-328X(95)00328-P
Klevanski, M., Herrmann, U., Weyer, S. W., Fol, R., Cartier, N., Wolfer, D. P.,
et al. (2015). The APP intracellular domain is required for normal synaptic
morphology, synaptic plasticity, and hippocampus-dependent behavior. J.
Neurosci. 35, 16018–16033. doi: 10.1523/jneurosci.2009-15.2015
Frontiers in Molecular Neuroscience | www.frontiersin.org 12 January 2017 | Volume 9 | Article 161
Ludewig and Korte Role of APP in Synaptic Plasticity
Klevanski, M., Saar, M., Baumkötter, F., Weyer, S. W., Kins, S., and Müller,
U. C. (2014). Differential role of APP and APLPs for neuromuscular
synaptic morphology and function. Mol. Cell. Neurosci. 61, 201–210.
doi: 10.1016/j.mcn.2014.06.004
Kögel, D., Deller, T., and Behl, C. (2012). Roles of amyloid precursor protein family
members in neuroprotection, stress signaling and aging. Exp. Brain Res. 217,
471–479. doi: 10.1007/s00221-011-2932-4
Korte, M., Herrmann, U., Zhang, X., and Draguhn, A. (2012). The role
of APP and APLP for synaptic transmission, plasticity, and network
function: lessons from genetic mouse models. Exp. Brain Res. 217, 435–440.
doi: 10.1007/s00221-011-2894-6
Korte, M., and Schmitz, D. (2016). Cellular and system biology of
memory: timing, molecules, and beyond. Physiol. Rev. 96, 647–693.
doi: 10.1152/physrev.00010.2015
Laßek, M., Weingarten, J., Acker-Palmer, A., Bajjalieh, S. M., Muller, U., and
Volknandt, W. (2014). Amyloid precursor protein knockout diminishes
synaptic vesicle proteins at the presynaptic active zone in mouse brain. Curr.
Alzheimer Res. 11, 971–980. doi: 10.2174/1567205011666141107152458
Laßek, M., Weingarten, J., Einsfelder, U., Brendel, P., Müller, U., and Volknandt,
W. (2013). Amyloid precursor proteins are constituents of the presynaptic
active zone. J. Neurochem. 127, 48–56. doi: 10.1111/jnc.12358
Laßek, M., Weingarten, J., Wegner, M., Mueller, B. F., Rohmer, M.,
Baeumlisberger, D., et al. (2016). APP Is a context-sensitive regulator of
the hippocampal presynaptic active zone. PLoS Comput. Biol. 12:e1004832.
doi: 10.1371/journal.pcbi.1004832
Laßek, M., Weingarten, J., Wegner, M., and Volknandt, W. (2015). The Amyloid
precursor protein-a novel player within the molecular array of presynaptic
nanomachines. Front. Synaptic Neurosci. 7:21. doi: 10.3389/fnsyn.2015.00021
Lawrence, J. L., Tong, M., Alfulaij, N., Sherrin, T., Contarino, M., White, M.
M., et al. (2014). Regulation of presynaptic Ca2+, synaptic plasticity and
contextual fear conditioning by a N-terminal α-amyloid fragment. J. Neurosci.
34, 14210–14218. doi: 10.1523/JNEUROSCI.0326-14.2014
LeBlanc, A. C., Papadopoulos, M., Bélair, C., Chu, W., Crosato, M., Powell,
J., et al. (1997). Processing of amyloid precursor protein in human
primary neuron and astrocyte cultures. J. Neurochem. 68, 1183–1190.
doi: 10.1046/j.1471-4159.1997.68031183.x
Lee, K. J., Moussa, C. E., Lee, Y., Sung, Y., Howell, B. W., Turner, R. S.,
et al. (2010). Beta amyloid-independent role of amyloid precursor protein in
generation and maintenance of dendritic spines. Neuroscience 169, 344–356.
doi: 10.1016/j.neuroscience.2010.04.078
Leissring, M. A., Murphy, M. P., Mead, T. R., Akbari, Y., Sugarman, M. C.,
Jannatipour, M., et al. (2002). A physiologic signaling role for the γ-secretase-
derived intracellular fragment of APP. Proc. Natl. Acad. Sci. U.S.A. 99,
4697–4702. doi: 10.1073/pnas.072033799
Li, H., Wang, B., Wang, Z., Guo, Q., Tabuchi, K., Hammer, R. E., et al. (2010).
Soluble amyloid precursor protein (APP) regulates transthyretin and Klotho
gene expression without rescuing the essential function of APP. Proc. Natl.
Acad. Sci. U.S.A. 107, 17362–17367. doi: 10.1073/pnas.1012568107
Li, S., Hong, S., Shepardson, N. E., Walsh, D. M., Shankar, G. M., and Selkoe, D.
(2009). Soluble oligomers of amyloid β protein facilitate hippocampal long-
term depression by disrupting neuronal glutamate uptake.Neuron 62, 788–801.
doi: 10.1016/j.neuron.2009.05.012
Liu, X., Yu, X., Zack, D. J., Zhu, H., and Qian, J. (2008). TiGER: a database
for tissue-specific gene expression and regulation. BMC Bioinformatics 9:271.
doi: 10.1186/1471-2105-9-271
Lorent, K., Overbergh, L., Moechars, D., De, S. B., Van, L. F., and Van den
Berghe, H. (1995). Expression in mouse embryos and in adult mouse brain
of three members of the amyloid precursor protein family, of the α-2-
macroglobulin receptor/low density lipoprotein receptor-related protein and
of its ligands apolipoprotein E, lipoprotein lipase, α-2-macroglobulin and
the 40,000 molecular weight receptor-associated protein. Neuroscience 65,
1009–1025. doi: 10.1016/0306-4522(94)00555-J
Mayer, M. C., Schauenburg, L., Thompson-Steckel, G., Dunsing, V., Kaden, D.,
Voigt, P., et al. (2016). Amyloid precursor-like protein 1 (APLP1) exhibits
stronger zinc-dependent neuronal adhesion than amyloid precursor protein
and APLP2. J. Neurochem. 137, 266–276. doi: 10.1111/jnc.13540
Midthune, B., Tyan, S.-H., Walsh, J. J., Sarsoza, F., Eggert, S., Hof, P. R., et al.
(2012). Deletion of the amyloid precursor-like protein 2 (APLP2) does not
affect hippocampal neuron morphology or function. Mol. Cell. Neurosci. 49,
448–455. doi: 10.1016/j.mcn.2012.02.001
Milosch, N., Tanriover, G., Kundu, A., Rami, A., Francois, J. C., Baumkotter, F.,
et al. (2014). Holo-APP and G-protein-mediated signaling are required for
sAPPα-induced activation of the Akt survival pathway. Cell Death Dis. 5:e1391.
doi: 10.1038/cddis.2014.352
Minkeviciene, R., Rheims, S., Dobszay, M. B., Zilberter, M.,
Hartikainen, J., Fülöp, L., et al. (2009). Amyloid β-induced neuronal
hyperexcitability triggers progressive epilepsy. J. Neurosci. 29, 3453–3462.
doi: 10.1523/JNEUROSCI.5215-08.2009
Moreno, L., Rose, C., Mohanraj, A., Allinquant, B., Billard, J.-M., and Dutar,
P. (2015). sAβPPα improves hippocampal NMDA-dependent functional
alterations linked to healthy aging. J. Alzheimers Dis. 48, 927–935.
doi: 10.3233/JAD-150297
Mucke, L., and Selkoe, D. J. (2012). Neurotoxicity of amyloid β-protein:
synaptic and network dysfunction. Cold Spring Harb. Perspect. Med. 2:a006338.
doi: 10.1101/cshperspect.a006338
Müller, U. C., and Zheng, H. (2012). Physiological functions of
APP family proteins. Cold Spring Harb. Perspect. Med. 2:a006288.
doi: 10.1101/cshperspect.a006288
Nitsch, R. M., Deng, A., Wurtman, R. J., and Growdon, J. H. (1997).
Metabotropic glutamate receptor subtype mGluR1α stimulates the secretion
of the amyloid β-protein precursor ectodomain. J. Neurochem. 69, 704–712.
doi: 10.1046/j.1471-4159.1997.69020704.x
Nitsch, R. M., Farber, S. A., Growdon, J. H., and Wurtman, R. J. (1993).
Release of amyloid β-protein precursor derivatives by electrical depolarization
of rat hippocampal slices. Proc. Natl. Acad. Sci. U.S.A. 90, 5191–5193.
doi: 10.1073/pnas.90.11.5191
Nitsch, R. M., Slack, B. E., Wurtman, R. J., and Growdon, J. H. (1992).
Release of Alzheimer amyloid precursor derivatives stimulated by
activation of muscarinic acetylcholine receptors. Science 258, 304–307.
doi: 10.1126/science.1411529
Norstrom, E. M., Zhang, C., Tanzi, R., and Sisodia, S. S. (2010). Identification
of NEEP21 as a ss-amyloid precursor protein-interacting protein in vivo that
modulates amyloidogenic processing in vitro. J. Neurosci. 30, 15677–15685.
doi: 10.1523/JNEUROSCI.4464-10.2010
Palop, J. J., Chin, J., Roberson, E. D., Wang, J., Thwin, M. T., Bien-Ly, N., et al.
(2007). Aberrant excitatory neuronal activity and compensatory remodeling
of inhibitory hippocampal circuits in mouse models of Alzheimer’s disease.
Neuron 55, 697–711. doi: 10.1016/j.neuron.2007.07.025
Park, J. H., Gimbel, D. A., GrandPre, T., Lee, J.-K., Kim, J.-E., Li, W.,
et al. (2006). Alzheimer precursor protein interaction with the Nogo-66
receptor reduces amyloid-β plaque deposition. J. Neurosci. 26, 1386–1395.
doi: 10.1523/JNEUROSCI.3291-05.2006
Perez, R. G., Soriano, S., Hayes, J. D., Ostaszewski, B., Xia, W., Selkoe, D.
J., et al. (1999). Mutagenesis identifies new signals for β-amyloid precursor
protein endocytosis, turnover, and the generation of secreted fragments,
including Aβ42. J. Biol. Chem. 274, 18851–18856. doi: 10.1074/jbc.274.27.
18851
Portelius, E., Price, E., Brinkmalm, G., Stiteler, M., Olsson, M., Persson, R., et al.
(2011). A novel pathway for amyloid precursor protein processing. Neurobiol.
Aging 32, 1090–1098. doi: 10.1016/j.neurobiolaging.2009.06.002
Prox, J., Bernreuther, C., Altmeppen, H., Grendel, J., Glatzel, M., D’Hooge,
R., et al. (2013). Postnatal disruption of the disintegrin/metalloproteinase
ADAM10 in brain causes epileptic seizures, learning deficits, altered spine
morphology, and defective synaptic functions. J. Neurosci. 33, 12915–28,
12928a. doi: 10.1523/jneurosci.5910-12.2013
Puzzo, D., Privitera, L., Leznik, E., Fa, M., Staniszewski, A., Palmeri,
A., et al. (2008). Picomolar amyloid-α positively modulates synaptic
plasticity and memory in hippocampus. J. Neurosci. 28, 14537–14545.
doi: 10.1523/JNEUROSCI.2692-08.2008
Reinhard, C., Borgers, M., David, G., and De Strooper, B. (2013). Soluble
amyloid-β precursor protein binds its cell surface receptor in a cooperative
fashion with glypican and syndecan proteoglycans. J. Cell Sci. 126, 4856–4861.
doi: 10.1242/jcs.137919
Ring, S., Weyer, S. W., Kilian, S. B., Waldron, E., Pietrzik, C. U., Filippov, M. A.,
et al. (2007). The secreted α-amyloid precursor protein ectodomain APPsα
is sufficient to rescue the anatomical, behavioral, and electrophysiological
Frontiers in Molecular Neuroscience | www.frontiersin.org 13 January 2017 | Volume 9 | Article 161
Ludewig and Korte Role of APP in Synaptic Plasticity
abnormalities of APP-deficient mice. J. Neurosci. 27, 7817–7826.
doi: 10.1523/JNEUROSCI.1026-07.2007
Ripoli, C., Cocco, S., Li Puma, D. D., Piacentini, R., Mastrodonato, A.,
Scala, F., et al. (2014). Intracellular accumulation of amyloid-α (Aα)
protein plays a major role in Aα-induced alterations of glutamatergic
synaptic transmission and plasticity. J. Neurosci. 34, 12893–12903.
doi: 10.1523/JNEUROSCI.1201-14.2014
Robakis, N. K., Ramakrishna, N., Wolfe, G., and Wisniewski, H. M.
(1987). Molecular cloning and characterization of a cDNA encoding the
cerebrovascular and the neuritic plaque amyloid peptides. Proc. Natl. Acad. Sci.
U.S.A. 84, 4190–4194. doi: 10.1073/pnas.84.12.4190
Rohan de Silva, H. A., Jen, A., Wickenden, C., Jen, L. S., Wilkinson, S. L., and Patel,
A. J. (1997). Cell-specific expression of β-amyloid precursor protein isoform
mRNAs and proteins in neurons and astrocytes. Brain Res. Mol. Brain Res. 47,
147–156. doi: 10.1016/S0169-328X(97)00045-4
Ryan, M. M., Morris, G. P., Mockett, B. G., Bourne, K., Abraham, W. C., Tate,
W. P., et al. (2013). Time-dependent changes in gene expression induced by
secreted amyloid precursor protein-α in the rat hippocampus. BMC Genomics
14:376. doi: 10.1186/1471-2164-14-376
Sabo, S. L., Lanier, L. M., Ikin, A. F., Khorkova, O., Sahasrabudhe, S.,
Greengard, P., et al. (1999). Regulation of β-amyloid secretion by FE65, an
amyloid protein precursor-binding protein. J. Biol. Chem. 274, 7952–7957.
doi: 10.1074/jbc.274.12.7952
Salgado-Puga, K., and Pena-Ortega, F. (2015). Cellular and network mechanisms
underlying memory impairment induced by amyloid β protein. Protein Pept.
Lett. 22, 303–321. doi: 10.2174/0929866522666150202112154
Sánchez-Alavez, M., Chan, S. L., Mattson, M. P., and Criado, J. R. (2007).
Electrophysiological and cerebrovascular effects of the α-secretase-derived
form of amyloid precursor protein in young and middle-aged rats. Brain Res.
1131, 112–117. doi: 10.1016/j.brainres.2006.10.074
Schwenk, J., Pérez-Garci, E., Schneider, A., Kollewe, A., Gauthier-Kemper, A.,
Fritzius, T., et al. (2016). Modular composition and dynamics of native GABAB
receptors identified by high-resolution proteomics. Nat. Neurosci. 19, 233–242.
doi: 10.1038/nn.4198
Seabrook, G. R., Smith, D. W., Bowery, B. J., Easter, A., Reynolds, T.,
Fitzjohn, S. M., et al. (1999). Mechanisms contributing to the deficits in
hippocampal synaptic plasticity in mice lacking amyloid precursor protein.
Neuropharmacology 38, 349–359. doi: 10.1016/S0028-3908(98)00204-4
Selkoe, D. J. (2002). Alzheimer’s disease is a synaptic failure. Science 298, 789–791.
doi: 10.1126/science.1074069
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E.,
Smith, I., et al. (2008). Amyloid-β protein dimers isolated directly from
Alzheimer’s brains impair synaptic plasticity and memory. Nat. Med. 14,
837–842. doi: 10.1038/nm1782
Slunt, H. H., Thinakaran, G., Von Koch, C., Lo, A. C., Tanzi, R. E., and Sisodia, S.
S. (1994). Expression of a ubiquitous, cross-reactive homologue of the mouse
β-amyloid precursor protein (APP). J. Biol. Chem. 269, 2637–2644.
Soba, P., Eggert, S., Wagner, K., Zentgraf, H., Siehl, K., Kreger, S., et al. (2005).
Homo- and heterodimerization of APP family members promotes intercellular
adhesion. EMBO J. 24, 3624–3634. doi: 10.1038/sj.emboj.7600824
Stahl, R., Schilling, S., Soba, P., Rupp, C., Hartmann, T., Wagner, K., et al. (2014).
Shedding of APP limits its synaptogenic activity and cell adhesion properties.
Front. Cell. Neurosci. 8:410. doi: 10.3389/fncel.2014.00410
Steinbach, J. P., Müller, U., Leist, M., Li, Z. W., Nicotera, P., and Aguzzi, A. (1998).
Hypersensitivity to seizures in β-amyloid precursor protein deficient mice. Cell
Death Differ. 5, 858–866. doi: 10.1038/sj.cdd.4400391
Strecker, P., Ludewig, S., Rust, M., Mundinger, T. A., Görlich, A., Krächan, E.
G., et al. (2016). FE65 and FE65L1 share common synaptic functions and
genetically interact with the APP family in neuromuscular junction formation.
Sci. Rep. 6:25652. doi: 10.1038/srep25652
Stuchlik, A. (2014). Dynamic learning and memory, synaptic plasticity
and neurogenesis: an update. Front. Behav. Neurosci. 8:106.
doi: 10.3389/fnbeh.2014.00106
Tan, J., and Evin, G. (2012). Beta-site APP-cleaving enzyme 1 trafficking
and Alzheimer’s disease pathogenesis. J. Neurochem. 120, 869–880.
doi: 10.1111/j.1471-4159.2011.07623.x
Taylor, C. J., Ireland, D. R., Ballagh, I., Bourne, K., Marechal, N. M., Turner, P.
R., et al. (2008). Endogenous secreted amyloid precursor protein-α regulates
hippocampal NMDA receptor function, long-term potentiation and spatial
memory. Neurobiol. Dis. 31, 250–260. doi: 10.1016/j.nbd.2008.04.011
Thinakaran, G., and Koo, E. H. (2008). Amyloid precursor protein
trafficking, processing, and function. J. Biol. Chem. 283, 29615–29619.
doi: 10.1074/jbc.R800019200
Tong, M., Arora, K., White, M. M., and Nichols, R. A. (2011). Role of key
aromatic residues in the ligand-binding domain of α7 nicotinic receptors
in the agonist action of β-amyloid. J. Biol. Chem. 286, 34373–34381.
doi: 10.1074/jbc.M111.241299
Turner, P. R., O’Connor, K., Tate, W. P., and Abraham, W. C. (2003).
Roles of amyloid precursor protein and its fragments in regulating
neural activity, plasticity and memory. Prog. Neurobiol. 70, 1–32.
doi: 10.1016/S0301-0082(03)00089-3
Tyan, S. H., Shih, A. Y., Walsh, J. J., Maruyama, H., Sarsoza, F., Ku, L., et al. (2012).
Amyloid precursor protein (APP) regulates synaptic structure and function.
Mol. Cell. Neurosci. 51, 43–52. doi: 10.1016/j.mcn.2012.07.009
van der Kant, R., and Goldstein, L. S. (2015). Cellular functions of the amyloid
precursor protein from development to dementia. Dev. Cell. 32, 502–515.
doi: 10.1016/j.devcel.2015.01.022
Vnencak, M., Paul, M. H., Hick, M., Schwarzacher, S. W., Del Turco, D., Muller,
U. C., et al. (2015). Deletion of the amyloid precursor-like protein 1 (APLP1)
enhances excitatory synaptic transmission, reduces network inhibition but does
not impair synaptic plasticity in the mouse dentate gyrus. J. Comp. Neurol. 523,
1717–1729. doi: 10.1002/cne.23766
Volianskis, A., and Jensen, M. S. (2003). Transient and sustained types of long-
term potentiation in the CA1 area of the rat hippocampus. J. Physiol. 550(Pt 2),
459–492. doi: 10.1113/jphysiol.2003.044214
von Koch, C. S., Zheng, H., Chen, H., Trumbauer, M., Thinakaran, G., van der
Ploeg, L. H., et al. (1997). Generation of APLP2 KO mice and early postnatal
lethality in APLP2/APP double KO mice. Neurobiol. Aging 18, 661–669.
doi: 10.1016/S0197-4580(97)00151-6
Walsh, D. M., Minogue, A. M., Sala Frigerio, C., Fadeeva, J. V., Wasco, W., and
Selkoe, D. J. (2007). The APP family of proteins: similarities and differences.
Biochem. Soc. Trans. 35(Pt 2), 416–420. doi: 10.1042/BST0350416
Walter, J., and Haass, C. (2000). Posttranslational modifications of amyloid
precursor protein: ectodomain phosphorylation and sulfation. Methods Mol.
Med. 32, 149–168. doi: 10.1385/1-59259-195-7:149.
Wang, B., Wang, Z., Sun, L., Yang, L., Li, H., Cole, A. L., et al. (2014). The
amyloid precursor protein controls adult hippocampal neurogenesis
through GABAergic interneurons. J. Neurosci. 34, 13314–13325.
doi: 10.1523/jneurosci.2848-14.2014
Wang, H., Megill, A., He, K., Kirkwood, A., and Lee, H. K. (2012). Consequences of
inhibiting amyloid precursor protein processing enzymes on synaptic function
and plasticity. Neural Plast. 2012:272374. doi: 10.1155/2012/272374
Wang, P., Yang, G., Mosier, D. R., Chang, P., Zaidi, T., Gong, Y. D.,
et al. (2005). Defective neuromuscular synapses in mice lacking amyloid
precursor protein (APP) and APP-Like protein 2. J. Neurosci. 25, 1219–1225.
doi: 10.1523/JNEUROSCI.4660-04.2005
Wang, Z., Yang, L., and Zheng, H. (2012). Role of APP and
Aα in synaptic physiology. Curr. Alzheimer Res. 9, 217–226.
doi: 10.2174/156720512799361691
Wasco, W., Gurubhagavatula, S., Paradis, M. D., Romano, D. M., Sisodia, S. S.,
Hyman, B. T., et al. (1993). Isolation and characterization of APLP2 encoding
a homologue of the Alzheimer’s associated amyloid β protein precursor. Nat.
Genet. 5, 95–100. doi: 10.1038/ng0993-95
Weyer, S. W., Klevanski, M., Delekate, A., Voikar, V., Aydin, D., Hick, M.,
et al. (2011). APP and APLP2 are essential at PNS and CNS synapses
for transmission, spatial learning and LTP. EMBO J. 30, 2266–2280.
doi: 10.1038/emboj.2011.119
Weyer, S.W., Zagrebelsky,M., Herrmann, U., Hick, M., Ganss, L., Gobbert, J., et al.
(2014). Comparative analysis of single and combined APP/APLP knockouts
reveals reduced spine density in APP-KO mice that is prevented by APPsα
expression. Acta Neuropathol. Commun. 2:36. doi: 10.1186/2051-5960-2-36
Willem, M., Tahirovic, S., Busche, M. A., Ovsepian, S. V., Chafai, M., Kootar, S.,
et al. (2015). eta-Secretase processing of APP inhibits neuronal activity in the
hippocampus. Nature 526, 443–447. doi: 10.1038/nature14864
Yang, L., Wang, Z., Wang, B., Justice, N. J., and Zheng, H. (2009). Amyloid
precursor protein regulates Cav1.2 L-type calcium channel levels and function
Frontiers in Molecular Neuroscience | www.frontiersin.org 14 January 2017 | Volume 9 | Article 161
Ludewig and Korte Role of APP in Synaptic Plasticity
to influence GABAergic short-term plasticity. J. Neurosci. 29, 15660–15668.
doi: 10.1523/JNEUROSCI.4104-09.2009
Yoshikai, S., Sasaki, H., Doh-ura, K., Furuya, H., and Sakaki, Y. (1990). Genomic
organization of the human amyloid β-protein precursor gene. Gene 87,
257–263. doi: 10.1016/0378-1119(90)90310-N
Zhang, X., Zhong, W., Brankack, J., Weyer, S. W., Müller, U. C., Tort, A. B., et al.
(2016). Impaired theta-γ coupling in APP-deficient mice. Sci. Rep. 6:21948.
doi: 10.1038/srep21948
Zou, C., Crux, S., Marinesco, S., Montagna, E., Sgobio, C., Shi, Y.,
et al. (2016). Amyloid precursor protein maintains constitutive and
adaptive plasticity of dendritic spines in adult brain by regulating D-
serine homeostasis. EMBO J. 35, 2213–2222. doi: 10.15252/embj.2016
94085
Zucker, R. S., and Regehr, W. G. (2002). Short-term synaptic plasticity. Annu. Rev.
Physiol. 64, 355–405. doi: 10.1146/annurev.physiol.64.092501.114547
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2017 Ludewig and Korte. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The use,
distribution or reproduction in other forums is permitted, provided the original
author(s) or licensor are credited and that the original publication in this journal
is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Molecular Neuroscience | www.frontiersin.org 15 January 2017 | Volume 9 | Article 161
